aspirin has been researched along with clofibric acid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feller, DR; Kamanna, VS; Kim, SK; Kim, SU; McCreery, RL; Newman, HA; Romstedt, KJ; Sternitzke, KD; Tehim, AK; Witiak, DT | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Fujiwara, R; Koga, T; Nakajima, M; Yokoi, T | 1 |
| Bruseghini, L; Vilageliu, J | 1 |
| Keller, BJ; Thurman, RG; Yamanaka, H | 1 |
| Hanioka, N; Kawashima, Y; Kozuka, H; Matsumura, M | 1 |
| Díez, MM; Fernández, A; Gil, M; Lasierra, J; Velázquez, E; Viladés, E | 1 |
| Kawashima, Y; Kozuka, H; Nakagawa, S; Tachibana, Y | 1 |
| Hirose, A; Kawashima, Y; Kozuka, H | 1 |
| Bruseghini, L; Dalmau, J; Vicens, B; Zapatero, J | 1 |
| Cibulova, L; Fedelesova, V; Gajdos, M; Huttova, D; Krivosikova, Z; Mongiellova, V; Polak, F | 1 |
| Cibulová, L; Dzúrik, R; Gajdos, M; Huttová, D; Krivosíková, Z; Mongiellová, V; Spustová, V | 1 |
| Drackley, JK; Odle, J; Yu, XX | 1 |
| Couturaud, F; Lacut, K; Le Gal, G; Leroyer, C; Louis, S; Mottier, D; Oger, E | 1 |
| Falkner, B; Keilson, LM; Moser, M; Weber, MA | 1 |
| Athyros, VG; Kakafika, AI; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP | 1 |
| Al Nuaim, M; Bryant, S; Danil de Namor, AF; Howlin, B; Villanueva Salas, JA | 1 |
2 review(s) available for aspirin and clofibric acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Dyslipidaemia, hypercoagulability and the metabolic syndrome.
Topics: Adipose Tissue; Adiposity; Animals; Aspirin; Cardiovascular Diseases; Cholesterol, HDL; Clofibric Acid; Dyslipidemias; Factor VII; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation Mediators; Insulin Resistance; Life Style; Lipoproteins, LDL; Metabolic Syndrome; Obesity; Plasminogen Activator Inhibitor 1; Thrombophilia; Triglycerides; von Willebrand Factor | 2006 |
2 trial(s) available for aspirin and clofibric acid
| Article | Year |
|---|---|
Plafibride tolerance trial in healthy volunteers.
Topics: Adult; Aspirin; Clofibrate; Clofibric Acid; Double-Blind Method; Erythrocyte Count; Humans; Hypolipidemic Agents; Leukocyte Count; Lipids; Platelet Aggregation | 1981 |
Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects.
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet-Derived Growth Factor | 2001 |
13 other study(ies) available for aspirin and clofibric acid
| Article | Year |
|---|---|
Synthetic aci-reductones: 3,4-dihydroxy-2H-1-benzopyran-2-ones and their cis- and trans-4a,5,6,7,8,8a-hexahydro diastereomers. Antiaggregatory, antilipidemic, and redox properties compared to those of the 4-substituted 2-hydroxytetronic acids.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Ascorbic Acid; Blood Platelets; Chemical Phenomena; Chemistry; Cholesterol; Coumarins; Humans; Hydrogen-Ion Concentration; Hypolipidemic Agents; Male; Oxidation-Reduction; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Structure-Activity Relationship; Triglycerides | 1988 |
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Comet Assay; DNA Damage; Glucuronides; Glucuronosyltransferase; HEK293 Cells; Hepatocytes; Humans; Kidney | 2011 |
[ITA 104, a product of antiplatelet aggregation activity].
Topics: Adenosine Diphosphate; Animals; Aspirin; Clofibrate; Clofibric Acid; Depression, Chemical; Dogs; Platelet Aggregation; Rats | 1978 |
Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.
Topics: Animals; Aspirin; Cell Division; Clofibrate; Clofibric Acid; Dose-Response Relationship, Drug; Female; Fibric Acids; Hypolipidemic Agents; L-Lactate Dehydrogenase; Microbodies; Mitochondria, Liver; Oxygen Consumption; Rats; Rats, Inbred Strains; Trypan Blue; Valproic Acid | 1992 |
Induction of microsomal stearoyl-CoA desaturation by the administration of various peroxisome proliferators.
Topics: Adipates; Animals; Aspirin; Clofibric Acid; Dibutyl Phthalate; Diethylhexyl Phthalate; Enzyme Induction; Fatty Acid Desaturases; Lipids; Male; Microbodies; Microsomes, Liver; Organoids; Probucol; Rats; Rats, Inbred Strains; Stearoyl-CoA Desaturase | 1983 |
[Evaluation of the effects of plafibride and lysine acetyl salicylate on the production of PGI2].
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Clofibrate; Clofibric Acid; Diet, Atherogenic; Epoprostenol; Lysine; Male; Platelet Aggregation; Rabbits | 1983 |
Effects of peroxisome proliferators on fatty acid-binding protein in rat liver.
Topics: Adipates; Animals; Aspirin; Binding Sites; Carrier Proteins; Chromatography, Affinity; Clofibric Acid; Cytosol; Diethylhexyl Phthalate; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Alcohols; Liver; Male; Microbodies; Neoplasm Proteins; Nerve Tissue Proteins; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1983 |
Selective increase in acylation of 1-acylglycerophosphorylcholine in livers of rats and mice by peroxisome proliferators.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acylation; Acyltransferases; Animals; Aspirin; Clofibrate; Clofibric Acid; Fatty Alcohols; Glycerylphosphorylcholine; Guinea Pigs; Hypolipidemic Agents; Liver; Lysophosphatidylcholines; Male; Mice; Microbodies; Microsomes, Liver; Rats; Rats, Inbred Strains | 1984 |
[The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fibrinogen; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboxane B2 | 1999 |
Differential induction of peroxisomal beta-oxidation enzymes by clofibric acid and aspirin in piglet tissues.
Topics: Acyl-CoA Oxidase; Animals; Animals, Newborn; Aspirin; Body Weight; Carnitine O-Palmitoyltransferase; Catalase; Clofibric Acid; Cyclooxygenase Inhibitors; Diet; Eating; Enzyme Induction; Hypolipidemic Agents; Isocitrate Dehydrogenase; Kidney; Liver; Mitochondria; Muscle, Skeletal; Myocardium; Organ Specificity; Oxidation-Reduction; Oxidoreductases; Peroxisome Proliferators; Peroxisomes; Random Allocation; Swine | 2001 |
Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study.
Topics: Aged; Aspirin; Case-Control Studies; Clofibric Acid; Confidence Intervals; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Risk; Ultrasonography; Venous Thrombosis | 2004 |
The metabolic syndrome--what is it and how should it be managed?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Metabolic Syndrome; Obesity; Weight Loss | 2006 |
A calix[4]arene derivative and its selective interaction with drugs (clofibric acid, diclofenac and aspirin).
Topics: Aspirin; Calixarenes; Calorimetry; Clofibric Acid; Diclofenac; Electric Conductivity; Models, Molecular; Phenols; Proton Magnetic Resonance Spectroscopy; Spectrophotometry, Ultraviolet; Thermodynamics | 2017 |